CEACAM5 and neoplasm: To assess the clinical utility and difference between the ctDNA and CEA levels in patients with mCRC, both associations between the ctDNA and CEA levels and the sum of tumor diameters were investigated, as estimated from standard response evaluation criteria in solid tumors (RECIST) in patients with mCRC.